03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Cancer
Professor Nicholas van As: no photograph is held, so the clinician plate is shown instead.
Clinician
Professor Nicholas van As
Chief Investigator of the PACE-A trial, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, and Professor in Precision Prostate Radiotherapy at The Institute of Cancer Research, London
2
2
0
Sept 2026Oct 2026Nov 2026to date
4
press citations on 1 topic since 28 Sept 2026 · last quoted 9 Oct 2026
02 Quoted on · 1 of 29 topics
Professor Nicholas van As: key facts
- Kind of voice
- Clinician
- Role
- Chief Investigator of the PACE-A trial, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, and Professor in Precision Prostate Radiotherapy at The Institute of Cancer Research, London
- Quoted on
- Cancer
- Tracked press citations
- 4
- Most recently quoted
- 9 Oct 2026
- First quoted
- 28 Sept 2026
04 The signal · where Professor Nicholas van As sits on cancer
Ranked 17= of 100 voices quoted in the press on cancer, level with 14 others on 4 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Prof Peter JohnsonClinicianNational Clinical Director for Cancer, NHS England23 - 2
Professor Victoria Tzortziou BrownClinicianChair of Council, Royal College of General Practitioners (RCGP)17 - 3Dr Claire FullerClinicianNational Medical Director, NHS England15
- 17=Muy-Teck TehAcademicProfessor of Molecular Oral Oncology at Queen Mary4
- 17=Raymond MakClinicianDr (one of the study's authors, Mass General Brigham)4
- 17=Professor Nicholas van AsClinicianChief Investigator of the PACE-A trial, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, and Professor in Precision Prostate Radiotherapy at The Institute of Cancer Research, London4
- 17=Professor Derek RosarioClinicianconsultant urological surgeon and clinical advisor to the UK NSC4
- 17=Genevieve EdwardsSector leaderchief executive of Bowel Cancer UK4
Showing the leaders and the ranks around 17=, of 100 voices · See every voice on the topic →
05 On the record · press
What Professor Nicholas van As has said
By outlet · linked articles
- independent.co.uk1
- oncodaily.com1
- reuters.com1
- theargus.co.uk1
Where Professor Nicholas van As has been quoted
- 01NEWSLETTER: Blindness treatment based on Nobel-winning research shows promisereuters.com · 9 Oct 2026
- 02Targeted radiotherapy found as effective as surgery for prostate cancertheargus.co.uk · 1 Oct 2026
- 03Advanced Radiotherapy as an Alternative to Surgery in Localised Prostate Cancer - The Royal Marsden NHS Foundation Trustoncodaily.com · 30 Sept 2026
- 04Researchers find prostate cancer treatment that is ‘as effective as’ surgeryindependent.co.uk · 28 Sept 2026
Verbatim
“What we can say is that... we have mature data showing excellent cancer outcomes with five-treatment radiotherapy.”
“Now, these results show that SBRT appears to achieve comparable long-term cancer control to surgery, helping patients make more informed decisions about their care.”
“Now, these results show that SBRT appears to achieve comparable long-term cancer control to surgery, helping patients make more informed decisions about their care.”
“It is essential that patients with prostate cancer are aware of all the options available to them”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.